AAA fully acquires Atreus Pharmaceuticals; enrolls first patient in a Phase I/II clinical trial for Annexin V-128
8 January 2015 | By Advanced Accelerator Applications S.A.
Advanced Accelerator Applications S.A. announced that it has acquired the remaining 49.9% of Atreus Pharmaceuticals Corporation, a development-stage biopharmaceutical company headquartered in Ottawa, Canada...